2020 Q2 Form 10-Q Financial Statement

#000156459020028432 Filed on June 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $124.2M $167.6M $198.0M
YoY Change -35.77% -15.38% -10.07%
Cost Of Revenue $40.79M $55.37M $61.68M
YoY Change -28.42% -10.23% -9.17%
Gross Profit $83.43M $112.2M $136.4M
YoY Change -38.84% -17.71% -10.47%
Gross Profit Margin 67.16% 66.96% 68.86%
Selling, General & Admin $10.87M $17.84M $22.01M
YoY Change -24.66% -18.95% 20.26%
% of Gross Profit 13.03% 15.9% 16.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $52.66M $55.90M $69.79M
YoY Change -18.32% -19.9% -2.73%
% of Gross Profit 63.13% 49.82% 51.18%
Operating Expenses $63.78M $73.90M $266.4M
YoY Change -64.08% -72.27% 51.34%
Operating Profit $19.65M $38.31M -$130.1M
YoY Change -147.78% -129.45% -394.74%
Interest Expense $52.63M $46.99M $54.00M
YoY Change 0.28% -12.97% 0.43%
% of Operating Profit 267.83% 122.65%
Other Income/Expense, Net -$71.31M -$43.96M $21.61M
YoY Change 56.59% -303.44%
Pretax Income -$56.68M -$138.8M -$46.67M
YoY Change 96.28% 197.34% 3490.0%
Income Tax $16.12M $526.0K $139.0K
% Of Pretax Income
Net Earnings -$70.23M -$122.7M -$38.98M
YoY Change 190.48% 214.74% -4416.28%
Net Earnings / Revenue -56.54% -73.21% -19.68%
Basic Earnings Per Share
Diluted Earnings Per Share -$365.8K -$684.8K -$225.0K
COMMON SHARES
Basic Shares Outstanding 192.0M 175.6M 173.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $123.4M $159.1M $21.06M
YoY Change 502.39% 655.72% -9.64%
Cash & Equivalents $123.4M $159.1M $21.06M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $125.9M $72.16M $71.36M
Other Receivables $5.457M $10.15M $9.855M
Total Short-Term Assets $254.8M $241.4M $102.3M
YoY Change 151.21% 136.07% -7.7%
LONG-TERM ASSETS
Property, Plant & Equipment $3.836B $3.892B $4.609B
YoY Change -15.23% -15.55% -9.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $453.6M $299.8M $277.4M
YoY Change 67.45% 8.09% -9.42%
Other Assets $26.74M $26.01M $14.17M
YoY Change 83.54%
Total Long-Term Assets $4.400B $4.480B $5.060B
YoY Change -11.04% -11.46% -9.52%
TOTAL ASSETS
Total Short-Term Assets $254.8M $241.4M $102.3M
Total Long-Term Assets $4.400B $4.480B $5.060B
Total Assets $4.655B $4.721B $5.162B
YoY Change -7.78% -8.54% -9.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $227.1M $205.5M $277.3M
YoY Change -12.72% -25.89% 19.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $227.1M $205.5M $277.3M
YoY Change -12.72% -25.89% 19.3%
LONG-TERM LIABILITIES
Long-Term Debt $3.774B $3.790B $3.899B
YoY Change -2.38% -2.79% -7.35%
Other Long-Term Liabilities $24.65M
YoY Change
Total Long-Term Liabilities $3.774B $3.790B $3.923B
YoY Change -2.39% -3.4% -6.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $227.1M $205.5M $277.3M
Total Long-Term Liabilities $3.774B $3.790B $3.923B
Total Liabilities $4.025B $3.995B $4.200B
YoY Change -2.47% -4.89% -5.4%
SHAREHOLDERS EQUITY
Retained Earnings -$1.284B -$1.069B
YoY Change 20.1% 31.87%
Common Stock $1.920M $1.735M
YoY Change 10.66% 0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $630.1M $695.8M $900.5M
YoY Change
Total Liabilities & Shareholders Equity $4.655B $4.721B $5.162B
YoY Change -7.78% -8.54% -9.48%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$70.23M -$122.7M -$38.98M
YoY Change 190.48% 214.74% -4416.28%
Depreciation, Depletion And Amortization $52.66M $55.90M $69.79M
YoY Change -18.32% -19.9% -2.73%
Cash From Operating Activities -$358.0K $38.73M $55.49M
YoY Change -100.51% -30.2% -43.51%
INVESTING ACTIVITIES
Capital Expenditures -$13.65M -$22.76M -$26.43M
YoY Change -44.77% -13.88% -33.93%
Acquisitions
YoY Change
Other Investing Activities -$5.095M $290.0K $321.0K
YoY Change -113.38% -9.66% -85.9%
Cash From Investing Activities -$18.75M -$172.6M $13.74M
YoY Change -240.26% -1356.69% -148.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.000K $17.00K
YoY Change -82.35% -58.54%
Debt Paid & Issued, Net $84.55M
YoY Change
Cash From Financing Activities -15.89M 260.0M -81.32M
YoY Change -81.04% -419.68% 2.51%
NET CHANGE
Cash From Operating Activities -358.0K 38.73M 55.49M
Cash From Investing Activities -18.75M -172.6M 13.74M
Cash From Financing Activities -15.89M 260.0M -81.32M
Net Change In Cash -35.00M 126.1M -12.10M
YoY Change -35098.0% -1142.23% 25.52%
FREE CASH FLOW
Cash From Operating Activities -$358.0K $38.73M $55.49M
Capital Expenditures -$13.65M -$22.76M -$26.43M
Free Cash Flow $13.29M $61.49M $81.92M
YoY Change -86.04% -24.94% -40.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2020Q1 cbl Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Absolute Stockholder Return Metrics Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsAbsoluteStockholderReturnMetricsPercentage
0.3333
CY2020Q1 cbl Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Stockholder Return To National Association Of Real Estate Investment Trusts Retail Index Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsStockholderReturnToNationalAssociationOfRealEstateInvestmentTrustsRetailIndexPercentage
0.6666
CY2020Q1 cbl Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Stockholder Return To National Association Of Real Estate Investment Trusts Retail Index Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsStockholderReturnToNationalAssociationOfRealEstateInvestmentTrustsRetailIndexPercentage
0.6666
CY2020Q1 cbl Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Absolute Stockholder Return Metrics Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsAbsoluteStockholderReturnMetricsPercentage
0.3333
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P15Y
CY2020Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P20Y
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
75252000
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
CBL & ASSOCIATES PROPERTIES, INC.
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Entity File Number
EntityFileNumber
1-12494
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1545718
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2030 Hamilton Place Blvd.
CY2020Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37421
CY2020Q1 dei City Area Code
CityAreaCode
423
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
855-0001
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
191970853
CY2020Q1 us-gaap Land
Land
719142000
CY2019Q4 us-gaap Land
Land
730218000
CY2020Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
5360133000
CY2019Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
5631831000
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chattanooga
CY2020Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6079275000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
695834000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
806312000
CY2020Q1 us-gaap Minority Interest
MinorityInterest
29257000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
55553000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
725091000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1161351000
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
161173000
CY2019Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
190980000
CY2020Q1 us-gaap Other Receivables
OtherReceivables
10152000
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2349404000
CY2020Q1 cbl Real Estate Investment Property Net Before Development In Process
RealEstateInvestmentPropertyNetBeforeDevelopmentInProcess
3861021000
CY2019Q4 cbl Real Estate Investment Property Net Before Development In Process
RealEstateInvestmentPropertyNetBeforeDevelopmentInProcess
4012645000
CY2020Q1 us-gaap Development In Process
DevelopmentInProcess
31009000
CY2019Q4 us-gaap Development In Process
DevelopmentInProcess
49351000
CY2020Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3892030000
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4061996000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
159117000
CY2020Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
153150000
CY2020Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
153172000
CY2020Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
72157000
CY2019Q4 us-gaap Other Receivables
OtherReceivables
10792000
CY2019Q4 cbl Mortgage And Other Notes Receivable
MortgageAndOtherNotesReceivable
4662000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
299797000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
307354000
CY2020Q1 cbl Intangible Lease And Other Assets
IntangibleLeaseAndOtherAssets
131962000
CY2019Q4 cbl Intangible Lease And Other Assets
IntangibleLeaseAndOtherAssets
129474000
CY2020Q1 us-gaap Assets
Assets
4721315000
CY2019Q4 us-gaap Assets
Assets
4622346000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
3789692000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
3527015000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
205470000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
231306000
CY2020Q1 us-gaap Liabilities
Liabilities
3995162000
CY2019Q4 us-gaap Liabilities
Liabilities
3758321000
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
1062000
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
2160000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
191965622
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
191965622
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174115111
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174115111
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1920000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1741000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1977891000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1965897000
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6362049000
CY2020Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2218254000
CY2020Q1 cbl Mortgage And Other Notes Receivable
MortgageAndOtherNotesReceivable
2928000
CY2020Q1 cbl Management Developmentand Leasing Fees Revenues
ManagementDevelopmentandLeasingFeesRevenues
2092000
CY2019Q1 cbl Management Developmentand Leasing Fees Revenues
ManagementDevelopmentandLeasingFeesRevenues
2523000
CY2020Q1 us-gaap Other Income
OtherIncome
4309000
CY2019Q1 us-gaap Other Income
OtherIncome
4527000
CY2020Q1 us-gaap Revenues
Revenues
167574000
CY2019Q1 us-gaap Revenues
Revenues
198030000
CY2020Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
25709000
CY2019Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
28980000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55902000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69792000
CY2020Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
18448000
CY2019Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
19919000
CY2020Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
11208000
CY2019Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
12776000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17836000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22007000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24825000
CY2019Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
88150000
CY2020Q1 us-gaap Other General Expense
OtherGeneralExpense
158000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
262905000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
266449000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2397000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
489000
CY2020Q1 us-gaap Interest Expense
InterestExpense
46992000
CY2019Q1 us-gaap Interest Expense
InterestExpense
53998000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
71722000
CY2020Q1 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
140000
CY2019Q1 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
228000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
526000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
139000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3308000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43963000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21610000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139294000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-46809000
CY2020Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-16414000
CY2019Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-7758000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-207000
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-75000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-122673000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-38976000
CY2019Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
11223000
CY2020Q1 cbl Preferred Dividends Undeclared
PreferredDividendsUndeclared
11223000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-133896000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50199000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4622346000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
179133
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
173252
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139294000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-46809000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
22000
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
139272000
CY2019Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
46809000
CY2020Q1 cbl Operating Partnership Comprehensive Income Net Of Tax
OperatingPartnershipComprehensiveIncomeNetOfTax
16412000
CY2019Q1 cbl Operating Partnership Comprehensive Income Net Of Tax
OperatingPartnershipComprehensiveIncomeNetOfTax
7758000
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
207000
CY2019Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
75000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122653000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38976000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1032165000
CY2019Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-46356000
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
75.000
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
13010000
CY2019Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
11223000
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
863174
CY2019Q1 cbl Stock Issued During Period Value Common Stockand Restricted Stock Award Gross
StockIssuedDuringPeriodValueCommonStockandRestrictedStockAwardGross
717000
CY2019Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
57656
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
134000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
313000
CY2019Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
1033000
CY2019Q1 cbl Adjustments To Additional Paid In Capital Noncontrolling Interest Other
AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestOther
-1038000
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4450000
CY2019Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
455000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
958472000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
861865000
CY2020Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-138136000
CY2020Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
22000
CY2020Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
16333947
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1633345
CY2020Q1 cbl Stock Issued During Period Value Common Stockand Restricted Stock Award Gross
StockIssuedDuringPeriodValueCommonStockandRestrictedStockAwardGross
537000
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
116781
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
97000
CY2020Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
633000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
390000
CY2020Q1 cbl Adjustments To Additional Paid In Capital Noncontrolling Interest Other
AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestOther
-60000
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
731000
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
668000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
725091000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-139294000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-46809000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
55902000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
69792000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1990000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2304000
CY2020Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-687000
CY2019Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-551000
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
140000
CY2019Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
228000
CY2020Q1 cbl Gain Losson Insurance Proceeds
GainLossonInsuranceProceeds
511000
CY2019Q1 cbl Gain Losson Insurance Proceeds
GainLossonInsuranceProceeds
690000
CY2020Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
158000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1545000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2043000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24825000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
71722000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3308000
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4235000
CY2019Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5671000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2312000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1540000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-239000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
63000
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1424000
CY2019Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
387000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3746000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3826000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16847000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
76771000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38728000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55488000
CY2020Q1 us-gaap Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
22760000
CY2019Q1 us-gaap Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
26429000
CY2020Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
520000
CY2019Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
35260000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
153193000
CY2020Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
600000
CY2019Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
548000
CY2020Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
503000
CY2019Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
266000
CY2020Q1 cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
2679000
CY2019Q1 cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
566000
CY2020Q1 cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
4668000
CY2019Q1 cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
4979000
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
290000
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
321000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172631000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13737000
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
365000000
CY2019Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
941217000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
103582000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
978006000
CY2020Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1300000
CY2019Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
15107000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17000
CY2020Q1 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
63
CY2020Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
668000
CY2019Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
455000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
87000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
132000
CY2020Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
731000
CY2019Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
5593000
CY2019Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11223000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12949000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
259971000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-81321000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
126068000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12096000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59058000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57512000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185126000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45416000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
159117000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21055000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
175000
CY2019Q1 us-gaap Restricted Cash
RestrictedCash
79000
CY2020Q1 us-gaap Escrow Deposit
EscrowDeposit
25834000
CY2019Q1 us-gaap Escrow Deposit
EscrowDeposit
24282000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185126000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45416000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
25321000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
35659000
CY2020Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
26
CY2020Q1 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
63
CY2020Q1 cbl Number Of Associated Centers Owned
NumberOfAssociatedCentersOwned
23
CY2020Q1 cbl Number Of Associated Centers Owned
NumberOfAssociatedCentersOwned
23
CY2020Q1 cbl Number Of Community Centers Owned
NumberOfCommunityCentersOwned
6
CY2020Q1 cbl Number Of Community Centers Owned
NumberOfCommunityCentersOwned
6
CY2020Q1 cbl Number Of Office Buildings Owned
NumberOfOfficeBuildingsOwned
6
CY2020Q1 cbl Number Of Office Buildings Owned
NumberOfOfficeBuildingsOwned
6
CY2020Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
98
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
125000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
218000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
85000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
32000
CY2020Q1 us-gaap Lease Cost
LeaseCost
210000
CY2019Q1 us-gaap Lease Cost
LeaseCost
250000
CY2020Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2661981000
CY2019Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2970246000
CY2020Q1 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"> <span style="text-decoration:underline;">Carrying Value of Long-Lived Assets</span> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="Background-color:#FFFFFF;">The Company evaluates its real estate assets and investment in unconsolidated affiliates for impairment indicators whenever events or changes in circumstances indicate that recoverability of its investment in the asset is not reasonably assured. Furthermore, this evaluation is conducted no less frequently than quarterly, irrespective of changes in circumstances. The prolonged outbreak of the COVID-19 pandemic has resulted in sustained closure of the Company’s properties, as well as the cessation of the operations of certain of its tenants, which will likely result in a reduction in the revenues and cash flows of many of its properties due to the adverse financial impacts on its tenants, as well as reductions in other sources of income generated by its properties. In addition to reduced revenues, the Company’s ability to obtain sufficient financing for such properties may be impaired as well as its ability to lease or re-lease properties as a result of worsening market and economic conditions resulting from the COVID-19 pandemic.</span> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="Background-color:#FFFFFF;">As of March 31, 2020, the Company’s evaluation of impairment considered its estimate of cash flow declines caused by the COVID-19 pandemic, but its other assumptions, including estimated hold period, were generally unchanged given the highly uncertain environment. The worsening of estimated future cash flows due to a change in the Company’s plans, policies, or views of market and economic conditions as it relates to one or more of its properties adversely impacted by the COVID-19 pandemic could result in the recognition of substantial impairment charges on its assets, which could adversely impact its financial results. </span> <span style="color:#000000;">For the period ended March 31, 2020, the Company recorded $133,644 of impairment charges for two of its malls and six other properties had impairment indicators; however, based on the Company’s plans with respect to those properties and the economic environment as of March 31, 2020, no additional impairment charges were recorded.</span> </p>
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
161173000
CY2019Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
190980000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5224000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5540000
CY2020Q1 us-gaap Revenues
Revenues
167574000
CY2019Q1 us-gaap Revenues
Revenues
198030000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
220000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23908000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
48366000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
45869000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
118143000
CY2020Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
137394000
CY2019Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
159278000
CY2020Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
23779000
CY2019Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
31702000
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
161173000
CY2019Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
190980000
CY2020Q1 us-gaap Number Of Properties Subject To Ground Leases
NumberOfPropertiesSubjectToGroundLeases
8
CY2020Q1 cbl Lessee Leasing Arrangements Numberof Office Building Leases
LesseeLeasingArrangementsNumberofOfficeBuildingLeases
1
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P42Y8M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.081
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Other Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherAssets
141501000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Other Assets
EquityMethodInvestmentSummarizedFinancialInformationOtherAssets
154427000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
1680679000
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
1690459000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Mortgage And Other Indebtedness
EquityMethodInvestmentSummarizedFinancialInformationMortgageAndOtherIndebtedness
1422015000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Mortgage And Other Indebtedness
EquityMethodInvestmentSummarizedFinancialInformationMortgageAndOtherIndebtedness
1417644000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Other Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherLiabilities
32675000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Other Liabilities
EquityMethodInvestmentSummarizedFinancialInformationOtherLiabilities
41007000
CY2020Q1 us-gaap Interest Receivable
InterestReceivable
1082000
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114300000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114300000
CY2019Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
70800000
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24825000
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24825000
CY2019Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
70800000
CY2020Q1 cbl Number Of Entities Equity Method Of Accounting
NumberOfEntitiesEquityMethodOfAccounting
28
CY2020Q1 cbl Numberof Joint Venture Entities
NumberofJointVentureEntities
17
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Investment In Real Estate Assets Gross
EquityMethodInvestmentSummarizedFinancialInformationInvestmentInRealEstateAssetsGross
2288173000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Investment In Real Estate Assets Gross
EquityMethodInvestmentSummarizedFinancialInformationInvestmentInRealEstateAssetsGross
2293438000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Accumulated Depreciation
EquityMethodInvestmentSummarizedFinancialInformationAccumulatedDepreciation
819034000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Accumulated Depreciation
EquityMethodInvestmentSummarizedFinancialInformationAccumulatedDepreciation
803909000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Investment In Real Estate Net
EquityMethodInvestmentSummarizedFinancialInformationInvestmentInRealEstateNet
1469139000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Investment In Real Estate Net
EquityMethodInvestmentSummarizedFinancialInformationInvestmentInRealEstateNet
1489529000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Construction In Progress
EquityMethodInvestmentSummarizedFinancialInformationConstructionInProgress
70039000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Construction In Progress
EquityMethodInvestmentSummarizedFinancialInformationConstructionInProgress
46503000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Investment In Real Estate Assets Net Of Construction In Progress
EquityMethodInvestmentSummarizedFinancialInformationInvestmentInRealEstateAssetsNetOfConstructionInProgress
1539178000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Investment In Real Estate Assets Net Of Construction In Progress
EquityMethodInvestmentSummarizedFinancialInformationInvestmentInRealEstateAssetsNetOfConstructionInProgress
1536032000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
1454690000
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
1458651000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Equity Attributable To Parent Company
EquityMethodInvestmentSummarizedFinancialInformationEquityAttributableToParentCompany
146192000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Equity Attributable To Parent Company
EquityMethodInvestmentSummarizedFinancialInformationEquityAttributableToParentCompany
149376000
CY2020Q1 cbl Equity Method Investment Summarized Financial Information Equity Attributableto Other Investors
EquityMethodInvestmentSummarizedFinancialInformationEquityAttributabletoOtherInvestors
79797000
CY2019Q4 cbl Equity Method Investment Summarized Financial Information Equity Attributableto Other Investors
EquityMethodInvestmentSummarizedFinancialInformationEquityAttributabletoOtherInvestors
82432000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
225989000
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
231808000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
1680679000
CY2019Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
1690459000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
60514000
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
55867000
CY2020Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
5043000
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
6010000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3308000
CY2020Q1 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
29257000
CY2019Q4 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
55553000
CY2020Q1 us-gaap Variable Interest Entity Nonconsolidated Carrying Amount Assets
VariableInterestEntityNonconsolidatedCarryingAmountAssets
30031000
CY2020Q1 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
71877000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15232000
CY2020Q1 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
2601849000
CY2019Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
2695888000
CY2020Q1 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
1203075000
CY2019Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
847275000
CY2020Q1 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
3804924000
CY2020Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0485
CY2019Q4 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
3543163000
CY2019Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0502
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15232000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
16148000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
3789692000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
3527015000
CY2020Q1 cbl Numberof Malls Securing Credit Facility Collateral
NumberofMallsSecuringCreditFacilityCollateral
17
CY2020Q1 cbl Numberof Associated Centers Securing Credit Facility Collateral
NumberofAssociatedCentersSecuringCreditFacilityCollateral
3
CY2020Q1 cbl Number Of Subsidiaries Owned
NumberOfSubsidiariesOwned
36
CY2020Q1 cbl Ownership Interestin Guarantor Subsidiaryby Operating Partnership Percent
OwnershipInterestinGuarantorSubsidiarybyOperatingPartnershipPercent
1
CY2020Q1 cbl Line Of Credit Facility Payment Restrictions
LineOfCreditFacilityPaymentRestrictions
150,000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
3789692000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
118560000
CY2020Q1 cbl Debt Instrument Weighted Average Remaining Term To Maturity
DebtInstrumentWeightedAverageRemainingTermToMaturity
P3Y6M
CY2019 cbl Debt Instrument Weighted Average Remaining Term To Maturity
DebtInstrumentWeightedAverageRemainingTermToMaturity
P3Y8M12D
CY2020Q1 cbl Percentage Of Assignment Of Partnership Interest
PercentageOfAssignmentOfPartnershipInterest
1
CY2020Q1 us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
84546000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
118560000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
557328000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
465455000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1491825000
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
341398000
CY2020Q1 cbl Longterm Debt Maturities Repaymentsof Principalin Year Six
LongtermDebtMaturitiesRepaymentsofPrincipalinYearSix
36105000
CY2020Q1 cbl Longterm Debt Maturities Repaymentsof Principalafter Year Six
LongtermDebtMaturitiesRepaymentsofPrincipalafterYearSix
711636000
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3722307000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-9330000
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
2928000
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
4662000
CY2020Q1 us-gaap Revenues
Revenues
167574000
CY2020Q1 cbl Property Operating Expenses
PropertyOperatingExpenses
55365000
CY2020Q1 us-gaap Interest Expense
InterestExpense
46992000
CY2020Q1 us-gaap Other General Expense
OtherGeneralExpense
158000
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
140000
CY2020Q1 cbl Segment Profit Loss
SegmentProfitLoss
65199000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55902000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17836000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2397000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
133644000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
526000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1018000
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-139294000
CY2020Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
20332000
CY2019Q1 us-gaap Revenues
Revenues
198030000
CY2019Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
28139000
CY2019Q1 cbl Property Operating Expenses
PropertyOperatingExpenses
61675000
CY2019Q1 us-gaap Interest Expense
InterestExpense
53998000
CY2019Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
228000
CY2019Q1 cbl Segment Profit Loss
SegmentProfitLoss
82585000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69792000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22007000
CY2019Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
88150000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
489000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
71722000
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24825000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
139000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3308000
CY2019Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-46809000
CY2020Q1 us-gaap Assets
Assets
4721315000
CY2019Q4 us-gaap Assets
Assets
4622346000
CY2020Q1 cbl Environmental Liability Insurance Maximum Coverage Per Incident
EnvironmentalLiabilityInsuranceMaximumCoveragePerIncident
10000000
CY2020Q1 cbl Environmental Liability Insurance Annual Coverage Limit.
EnvironmentalLiabilityInsuranceAnnualCoverageLimit.
50000000
CY2020Q1 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
971000
CY2019Q4 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
973000
CY2020Q1 us-gaap Malpractice Loss Contingency Letters Of Credit And Surety Bonds
MalpracticeLossContingencyLettersOfCreditAndSuretyBonds
6384000
CY2019Q4 us-gaap Malpractice Loss Contingency Letters Of Credit And Surety Bonds
MalpracticeLossContingencyLettersOfCreditAndSuretyBonds
13660000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10400000
CY2020Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
7000
CY2019Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
14000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3165000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2020Q1 cbl Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Amended To Remove Granted Annually
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAmendedToRemoveGrantedAnnually
200000
CY2019Q1 cbl Increase Decrease In Accrued Dividends And Distributions
IncreaseDecreaseInAccruedDividendsAndDistributions
17191000
CY2020Q1 cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
19478000
CY2019Q1 cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
19757000
CY2019Q1 us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-60059000
CY2019Q1 us-gaap Mortgage Loans On Real Estate Foreclosures
MortgageLoansOnRealEstateForeclosures
124111000
CY2019Q1 cbl Increase Decreasein Operating Assetsand Liabilities
IncreaseDecreaseinOperatingAssetsandLiabilities
9333000
CY2019Q1 cbl Increase Decrease In Leased Intangible Assets Through Transfers
IncreaseDecreaseInLeasedIntangibleAssetsThroughTransfers
-1663000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
21051000
CY2020Q1 cbl Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-200000
CY2019Q1 cbl Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
4024000
dei Entity Central Index Key
EntityCentralIndexKey
0000910612
CY2020Q1 cbl Non Recourse Loan Default Additional Interest Rate Above Stated Interest Rate
NonRecourseLoanDefaultAdditionalInterestRateAboveStatedInterestRate
0.0300
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000910612
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32816000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1284024000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
861865000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4721315000

Files In Submission

Name View Source Status
0001564590-20-028432-index-headers.html Edgar Link pending
0001564590-20-028432-index.html Edgar Link pending
0001564590-20-028432.txt Edgar Link pending
0001564590-20-028432-xbrl.zip Edgar Link pending
cbl-20200331.htm Edgar Link pending
cbl-20200331.xsd Edgar Link pending
cbl-20200331_cal.xml Edgar Link unprocessable
cbl-20200331_def.xml Edgar Link unprocessable
cbl-20200331_htm.xml Edgar Link completed
cbl-20200331_lab.xml Edgar Link unprocessable
cbl-20200331_pre.xml Edgar Link unprocessable
cbl-ex311_13.htm Edgar Link pending
cbl-ex312_12.htm Edgar Link pending
cbl-ex313_11.htm Edgar Link pending
cbl-ex314_10.htm Edgar Link pending
cbl-ex321_9.htm Edgar Link pending
cbl-ex322_8.htm Edgar Link pending
cbl-ex323_6.htm Edgar Link pending
cbl-ex324_7.htm Edgar Link pending
cbl-ex99_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending